Mepolizumab and the treatment of chronic rhinosinusitis

The Lancet Respiratory Medicine in conversation with - A podcast by The Lancet Group

Categories:

Education

Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00097-7/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube....